TKI Targeted Therapy in Advanced Hepatocellular Cancer
Sort by:
OncoAlert
Year in Review: Gastric, Esophageal, & Liver Cancer Updates
FEATURING
Sharlene Gill
- 8 views
- April 17, 2025
14th International Gastrointestinal Cancers Conference (IGICC2024)
Management of Fibrolamellar Liver Cancer
FEATURING
Sunyoung Lee
- 11 views
- April 9, 2025
COR2ED The Heart of Medical Education
Advanced HCC: 2L Treatment Selection & When to Switch
- 40 views
- March 6, 2025
- 2
14th International Gastrointestinal Cancers Conference (IGICC2024)
Optimal Sequencing of Systemic Treatment for HCC
FEATURING
Sahin Lacin
- 16 views
- February 25, 2025
14th International Gastrointestinal Cancers Conference (IGICC2024)
Overview of Key Immunotherapy Trials in Advanced HCC
FEATURING
Vladimir Nikolic
- 75 views
- February 5, 2025
Oncology 2024 Year in Review
Year in Review 2024 - Hepatobiliary Cancers
FEATURING
Richard Kim,
Tiago Biachi
- 646 views
- December 30, 2024
- 3
Exelixis
Hypothetical Patient Case: RAI-R Metastatic Differentiated Thyroid Cancer and the BRAF V600E Mutation
FEATURING
Robert Alter,
Raji Shameem
- 241 views
- November 11, 2024
- 1
Exelixis
Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and Dose Management to Help Optimize Outcomes
FEATURING
Kirollos Hanna,
Joshua Strauss
- 523 views
- November 11, 2024
- 1
Exelixis
Hypothetical Patient Case: Hepatocellular Carcinoma and Considerations for 2L Treatment Post Sorafenib
FEATURING
Julio Gutierrez,
Joshua Strauss
- 164 views
- November 11, 2024
Exelixis
Hypothetical Patient Case: Hepatocellular Carcinoma with Progression from Child-Pugh A to Child-Pugh B Liver Function
FEATURING
Julio Gutierrez,
Joshua Strauss
- 239 views
- November 11, 2024
COR2ED The Heart of Medical Education
ESMO 2024 Summary: HCC Treatment Highlights
FEATURING
Richard S. Finn
- 58 views
- November 1, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: CheckMate 9DW Expanded Analysis - Nivo + Ipi vs. Len or Sorafenib in 1L Unresectable HCC
FEATURING
Hatim Karachiwala
- 146 views
- October 21, 2024
- 2
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Highlights in HCC
FEATURING
Richard Kim,
Tiago Biachi
- 299 views
- October 21, 2024
- 3
Angelo Pirozzi
Optimizing Therapy Selection for Frontline Treatment of Advanced HCC
- 140 views
- October 16, 2024
- 1
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Updates in HCC and Impacts on Practice
FEATURING
Hani Babiker
- 230 views
- October 14, 2024
- 2
COR2ED The Heart of Medical Education
Advanced HCC Case Discussion: Treatment Options for Patients With Autoimmune Disorders
FEATURING
Sammy Saab
- 40 views
- October 6, 2024
Integrity CE
Choosing the Best HCC Treatment Based on Patient and Disease Stage
- 234 views
- October 1, 2024
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Insights: TACE ± Lenvatinib + Pembro for Int-Stage HCC - Ph3 LEAP-012 Study
FEATURING
Josep Llovet
- 224 views
- September 23, 2024
- 3
2024 ESMO Annual Meeting Insights Hub
ESMO 2024 Summary: Selecting 1L Therapy and Sequencing After Immunotherapy in Unresectable HCC
FEATURING
Lorenza Rimassa
- 573 views
- September 20, 2024
- 8
UChicago Medicine Annual Practice Updates in Hematology and Oncology
UChicago Medicine Best of ASCO® 2024: HCC & BTC
FEATURING
Joseph Franses
- 49 views
- September 5, 2024
- 1